These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22020625)

  • 1. Decreased concentrations of retinol-binding protein 4 in sera of epithelial ovarian cancer patients: a potential biomarker identified by proteomics.
    Lorkova L; Pospisilova J; Lacheta J; Leahomschi S; Zivny J; Cibula D; Zivny J; Petrak J
    Oncol Rep; 2012 Feb; 27(2):318-24. PubMed ID: 22020625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics analysis for finding serum markers of ovarian cancer.
    Cheng Y; Liu C; Zhang N; Wang S; Zhang Z
    Biomed Res Int; 2014; 2014():179040. PubMed ID: 25250314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate biomarkers using the Experion™ automated electrophoresis system in serum samples from ovarian cancer patients.
    Kim JH; Kim YW; Kim IW; Park DC; Kim YW; Lee KH; Jang CK; Ahn WS
    Int J Oncol; 2013 Apr; 42(4):1257-62. PubMed ID: 23443953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Identification and prognostic value of differentially expressed proteins of patients with platinum resistance epithelial ovarian cancer in serum].
    Wu WJ; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jul; 51(7):515-23. PubMed ID: 27465871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis.
    Huang L; Zhou Y; Cao XP; Lin JX; Zhang L; Huang ST; Zheng M
    Tumour Biol; 2017 Jun; 39(6):1010428317706289. PubMed ID: 28651492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Moore LE; Pfeiffer RM; Zhang Z; Lu KH; Fung ET; Bast RC
    Cancer; 2012 Jan; 118(1):91-100. PubMed ID: 21717433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Targeted Mass Spectrometry Strategy for Developing Proteomic Biomarkers: A Case Study of Epithelial Ovarian Cancer.
    Hüttenhain R; Choi M; Martin de la Fuente L; Oehl K; Chang CY; Zimmermann AK; Malander S; Olsson H; Surinova S; Clough T; Heinzelmann-Schwarz V; Wild PJ; Dinulescu DM; Niméus E; Vitek O; Aebersold R
    Mol Cell Proteomics; 2019 Sep; 18(9):1836-1850. PubMed ID: 31289117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Pilot Study of Circulating MicroRNA-125b as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer.
    Zhu T; Gao W; Chen X; Zhang Y; Wu M; Zhang P; Wang S
    Int J Gynecol Cancer; 2017 Jan; 27(1):3-10. PubMed ID: 27636713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC).
    Rohr I; Braicu EI; En-Nia A; Heinrich M; Richter R; Chekerov R; Dechend R; Heidecke H; Dragun D; Schäfer R; Gorny X; Lindquist JA; Brandt S; Sehouli J; Mertens PR
    Cytokine; 2016 Sep; 85():157-64. PubMed ID: 27371774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis.
    Petri AL; Simonsen AH; Høgdall E; Christensen IJ; Kjaer SK; Yip C; Risum S; Pedersen AT; Hartwell D; Fung ET; Høgdall C
    Proteomics Clin Appl; 2010 Mar; 4(3):304-14. PubMed ID: 21137051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of serum biomarkers implicated in the onset and progression of serous ovarian cancer in a rat model using iTRAQ technique.
    Huang Y; Zhang X; Jiang W; Wang Y; Jin H; Liu X; Xu C
    Eur J Obstet Gynecol Reprod Biol; 2012 Nov; 165(1):96-103. PubMed ID: 22818854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
    Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
    Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinol-binding protein 4 levels and susceptibility to ischaemic events in men.
    Cubedo J; Padró T; Cinca J; Mata P; Alonso R; Badimon L
    Eur J Clin Invest; 2014; 44(3):266-75. PubMed ID: 24720534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretome-based identification of TFPI2, a novel serum biomarker for detection of ovarian clear cell adenocarcinoma.
    Arakawa N; Miyagi E; Nomura A; Morita E; Ino Y; Ohtake N; Miyagi Y; Hirahara F; Hirano H
    J Proteome Res; 2013 Oct; 12(10):4340-50. PubMed ID: 23805888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of human epididymis protein 4 in epithelial ovarian cancer.
    Paek J; Lee SH; Yim GW; Lee M; Kim YJ; Nam EJ; Kim SW; Kim YT
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):338-42. PubMed ID: 21683503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Profiling signatures of ovarian cancer tumour suppression using 2D-DIGE and 2D-LC-MS/MS with tandem mass tagging.
    Sinclair J; Metodieva G; Dafou D; Gayther SA; Timms JF
    J Proteomics; 2011 Apr; 74(4):451-65. PubMed ID: 21237297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-Specific Differential Glycosylation of Immunoglobulins in Serum of Ovarian Cancer Patients.
    Ruhaak LR; Kim K; Stroble C; Taylor SL; Hong Q; Miyamoto S; Lebrilla CB; Leiserowitz G
    J Proteome Res; 2016 Mar; 15(3):1002-10. PubMed ID: 26813784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of glycomic profiling as a diagnostic biomarker for epithelial ovarian cancer.
    Kim K; Ruhaak LR; Nguyen UT; Taylor SL; Dimapasoc L; Williams C; Stroble C; Ozcan S; Miyamoto S; Lebrilla CB; Leiserowitz GS
    Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):611-21. PubMed ID: 24557531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages.
    Kotowicz B; Fuksiewicz M; Sobiczewski P; Spiewankiewicz B; Jonska-Gmyrek J; Skrzypczak M; Kowalska M
    Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():141-6. PubMed ID: 26398337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical validation of multiple biomarkers suspension array technology for ovarian cancer].
    Zhao BB; Yang ZJ; Wang Q; Pan ZM; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2017 Jan; 52(1):11-19. PubMed ID: 28190310
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.